Samsung Bioepis Revenue and Competitors
Estimated Revenue & Valuation
- Samsung Bioepis's estimated annual revenue is currently $266.3M per year.
- Samsung Bioepis's estimated revenue per employee is $321,600
- Samsung Bioepis's total funding is $668M.
Employee Data
- Samsung Bioepis has 828 Employees.
- Samsung Bioepis grew their employee count by 5% last year.
Samsung Bioepis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | VP, Head US Commercial Operations & Market Access | Reveal Email/Phone |
3 | Head US Corporate Development | Reveal Email/Phone |
4 | National Account Director, Market Access, U.S. Business Development | Reveal Email/Phone |
5 | Director Corporate Finance | Reveal Email/Phone |
6 | National Account Manager | Reveal Email/Phone |
7 | Senior Finance Manager | Reveal Email/Phone |
8 | Senior Manager - Manufacturing & Supply Chain Operation | Reveal Email/Phone |
9 | Senior Manager Corporate Finance | Reveal Email/Phone |
10 | Human Resources Manager | Reveal Email/Phone |
Samsung Bioepis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Samsung Bioepis?
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology and ophthalmology. Samsung Bioepis is a joint venture between Samsung BioLogics and Biogen. For more information, please visit: www.samsungbioepis.com.
keywords:N/A
$668M
Total Funding
828
Number of Employees
$266.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Samsung Bioepis News
In addition to Amgen, Formycon, Samsung Bioepis, Bio-Thera Solutions, Hikma Pharmaceuticals, Alvotech, BioFactura, and NeuClone are in the...
Biogen has completed the sale of the company's equity stake in the Samsung Bioepis joint venture to Samsung Biologics for a total...
INCHEON -- With the buyout of Samsung Bioepis' stake, Samsung Biologics will become a global bio company based on the three pillars of...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $289.8M | 828 | 6% | N/A |
#2 | $380.2M | 828 | 32% | N/A |
#3 | $290.2M | 829 | 44% | N/A |
#4 | $208.9M | 829 | 21% | N/A |
#5 | $209.2M | 830 | 7% | N/A |